Glibenclamide Tablets IP 5 mg Supplier in India – Healthy Inc

Glibenclamide Tablets IP 5 mg | Supplier
Product image for Glibenclamide Tablets IP 5 mg Supplier; wholesale & institutional bulk supply.
Product Information
| Generic Name | Glibenclamide |
|---|---|
| Manufacturer | Healthy Life Pharma Pvt. Ltd. |
| HSN Code | 30049099 |
| Pharmacopoeia | IP |
| Product Type | Tablet |
| Category | Antidiabetic drugs |
| Subcategory | Antidiabetic drugs |
| Active Ingredient | Glibenclamide |
| Strength | 5 mg |
| Dosage Form | Tablet |
| Pack Size | 10 x 10 Tablets / Box (Alu-Alu / Blister) |
| Route of Administration | Oral |
| Prescription Required | Yes |
| Therapeutic Category | Antidiabetic drugs |
Medicine Details & Safety
| Short Description | Healthy Inc invites B2B supply enquiries for Glibenclamide Tablets IP 5 mg from licensed wholesalers, distributors, pharmacy procurement teams and institutional buyers. Order quantities, stock status, batch details and delivery schedules are confirmed before commercial acceptance. | ||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Approved Uses / Indications | 1. Monotherapy as an adjunct to diet and exercise for glycemic control in type 2 diabetes mellitus. 2. Combination therapy with other oral antidiabetic agents or insulin when dual therapy is required. | ||||||||||||||||||||||||||||||||||
| Full Description | Healthy Inc invites B2B supply enquiries for Glibenclamide Tablets IP 5 mg from licensed wholesalers, distributors, pharmacy procurement teams and institutional buyers. Order quantities, stock status, batch details and delivery schedules are confirmed before commercial acceptance. Product technical specifications
Product technical specifications
Supply channels and buyer segmentsHospital procurement teams and institutional tender buyers can submit tender specifications, required documentation and staggered delivery schedules. Wholesalers and pharmacy chains can request pack configurations and replenishment planning. PCD distributors may submit territory and commercial requirements for review.Commercial supply matrix
Inventory and batch traceabilityRequest available batch numbers, expiry details, COA and approved storage conditions for Glibenclamide Tablets IP 5 mg. Agree minimum remaining shelf life and stock rotation requirements before dispatch.Procurement and deliverySubmit purchase quantity, delivery location, buyer licence details and required documents. Confirm commercial terms, payment conditions, transport arrangements and repeat-order schedule. Stock and delivery are not guaranteed until confirmed. | ||||||||||||||||||||||||||||||||||
| Dosage Instructions | Administer orally with meals or immediately before food intake as directed by the physician. Recommended dosage should be individualized based on glycemic response and HbA1c targets. Maintain regular blood glucose self-monitoring during initiation and titration. | ||||||||||||||||||||||||||||||||||
| Side Effects | Common: Mild gastrointestinal discomfort, nausea, flatulence, abdominal fullness, diarrhea. Uncommon: Hypoglycemia (when combined with other antidiabetic agents), transient metallic taste, mild headache. Rare: Skin rash, urticaria, elevated hepatic transaminases. | ||||||||||||||||||||||||||||||||||
| Warnings and Precautions | Hypoglycemia Risk: Concomitant use with sulfonylureas or insulin secretagogues heightens hypoglycemic risk; ensure immediate access to fast-acting carbohydrates. Renal & Hepatic Monitoring: Periodically assess serum creatinine, eGFR, and liver function tests during long-term therapy. | ||||||||||||||||||||||||||||||||||
| Contraindications | 1. Known hypersensitivity to Glibenclamide or formulation excipients. 2. Diabetic ketoacidosis, hyperosmolar hyperglycemic state, or diabetic coma. 3. Severe renal impairment (eGFR < 30 mL/min) or advanced hepatic insufficiency. 4. Acute metabolic acidosis. | ||||||||||||||||||||||||||||||||||
| Drug Interactions | 1. Sulfonylureas, Meglitinides & Insulin: Enhanced hypoglycemic effect requiring dose adjustments. 2. Corticosteroids, Thiazides & Sympathomimetics: May attenuate glycemic control, requiring upward titration. 3. Alcohol: May potentiate hypoglycemia or risk of metabolic acidosis. |
Frequently Asked Questions
| Question | Answer |
|---|---|
| Who can request bulk supply for Glibenclamide Tablets IP 5 mg? | Licensed pharmaceutical wholesalers, distributors and institutional procurement teams can submit enquiries. |
| What is the minimum order quantity for Glibenclamide Tablets IP 5 mg? | MOQ is confirmed according to pack configuration and order requirements. |
| Is ready stock available for Glibenclamide Tablets IP 5 mg? | Request current stock and batch availability before placing an order. |
| Can institutional tender requirements be supported for Glibenclamide Tablets IP 5 mg? | Submit tender specifications and delivery schedule for feasibility review. |
| How can I request wholesale pricing for Glibenclamide Tablets IP 5 mg? | Provide quantity, delivery location and required packaging for a quotation. |
Related Products
✚
Glibenclamide Tablets BP 5 mg ExporterView product →
✚
Glibenclamide Tablets BP 5 mg ManufacturerView product →
✚
Glibenclamide Tablets BP 5 mg SupplierView product →
✚
Glibenclamide Tablets IP 5 mg ExporterView product →
✚
Glibenclamide Tablets IP 5 mg ManufacturerView product →
✚
Glicazide Tablets BP 80 mg ExporterView product →
✚
Glicazide Tablets BP 80 mg ManufacturerView product →
✚
Glicazide Tablets BP 80 mg SupplierView product →
✚
Glimepiride Tablets 1 mg ExporterView product →
✚
Glimepiride Tablets 1 mg ManufacturerView product →
✚
Glimepiride Tablets 1 mg SupplierView product →
✚
Glimepiride Tablets 2 mg ExporterView product →
